Cargando…

Protocol for the development of a core outcome set for lateral elbow tendinopathy (COS-LET)

BACKGROUND: Lateral elbow tendinopathy (LET) is a common condition that can cause significant disability and associated socioeconomic cost. Although it has been widely researched, outcome measures are highly variable which restricts evidence synthesis across studies. In 2019, a working group of inte...

Descripción completa

Detalles Bibliográficos
Autores principales: Bateman, Marcus, Evans, Jonathan P., Vuvan, Viana, Jones, Val, Watts, Adam C., Phadnis, Joideep, Bisset, Leanne, Vicenzino, Bill
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8111763/
https://www.ncbi.nlm.nih.gov/pubmed/33971941
http://dx.doi.org/10.1186/s13063-021-05291-9
_version_ 1783690565249925120
author Bateman, Marcus
Evans, Jonathan P.
Vuvan, Viana
Jones, Val
Watts, Adam C.
Phadnis, Joideep
Bisset, Leanne
Vicenzino, Bill
author_facet Bateman, Marcus
Evans, Jonathan P.
Vuvan, Viana
Jones, Val
Watts, Adam C.
Phadnis, Joideep
Bisset, Leanne
Vicenzino, Bill
author_sort Bateman, Marcus
collection PubMed
description BACKGROUND: Lateral elbow tendinopathy (LET) is a common condition that can cause significant disability and associated socioeconomic cost. Although it has been widely researched, outcome measures are highly variable which restricts evidence synthesis across studies. In 2019, a working group of international experts, health care professionals and patients, in the field of tendinopathy (International Scientific Tendinopathy Symposium Consensus (ICON) Group), published the results of a consensus exercise defining the nine core domains that should be measured in tendinopathy research. The aim of this study is to develop a core outcome set (COS) for LET mapping to these core domains. The primary output will provide a template for future outcome evaluation of LET. In this protocol, we detail the methodological approach to the COS-LET development. METHODS: This study will employ a three-phase approach. (1) A systematic review of studies investigating LET will produce a comprehensive list of all instruments currently employed to quantify the treatment effect or outcome. (2) Instruments will be matched to the list of nine core tendinopathy outcome domains by a Steering Committee of clinicians and researchers with a specialist interest in LET resulting in a set of candidate instruments. (3) An international three-stage Delphi study will be conducted involving experienced clinicians, researchers and patients. Within this Delphi study, candidate instruments will be selected based upon screening using the Outcome Measures in Rheumatology (OMERACT) truth, feasibility and discrimination filters with a threshold of 70% agreement set for consensus. CONCLUSIONS: There is currently no COS for the measurement or monitoring of LET in trials or clinical practice. The output from this project will be a minimum COS recommended for use in all future English language studies related to LET. The findings will be published in a high-quality journal and disseminated widely using professional networks, social media and via presentation at international conferences. TRIAL REGISTRATION: Registered with the Core Outcome Measures in Effectiveness Trials (COMET) database, November 2019. https://www.comet-initiative.org/Studies/Details/1497.
format Online
Article
Text
id pubmed-8111763
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-81117632021-05-11 Protocol for the development of a core outcome set for lateral elbow tendinopathy (COS-LET) Bateman, Marcus Evans, Jonathan P. Vuvan, Viana Jones, Val Watts, Adam C. Phadnis, Joideep Bisset, Leanne Vicenzino, Bill Trials Study Protocol BACKGROUND: Lateral elbow tendinopathy (LET) is a common condition that can cause significant disability and associated socioeconomic cost. Although it has been widely researched, outcome measures are highly variable which restricts evidence synthesis across studies. In 2019, a working group of international experts, health care professionals and patients, in the field of tendinopathy (International Scientific Tendinopathy Symposium Consensus (ICON) Group), published the results of a consensus exercise defining the nine core domains that should be measured in tendinopathy research. The aim of this study is to develop a core outcome set (COS) for LET mapping to these core domains. The primary output will provide a template for future outcome evaluation of LET. In this protocol, we detail the methodological approach to the COS-LET development. METHODS: This study will employ a three-phase approach. (1) A systematic review of studies investigating LET will produce a comprehensive list of all instruments currently employed to quantify the treatment effect or outcome. (2) Instruments will be matched to the list of nine core tendinopathy outcome domains by a Steering Committee of clinicians and researchers with a specialist interest in LET resulting in a set of candidate instruments. (3) An international three-stage Delphi study will be conducted involving experienced clinicians, researchers and patients. Within this Delphi study, candidate instruments will be selected based upon screening using the Outcome Measures in Rheumatology (OMERACT) truth, feasibility and discrimination filters with a threshold of 70% agreement set for consensus. CONCLUSIONS: There is currently no COS for the measurement or monitoring of LET in trials or clinical practice. The output from this project will be a minimum COS recommended for use in all future English language studies related to LET. The findings will be published in a high-quality journal and disseminated widely using professional networks, social media and via presentation at international conferences. TRIAL REGISTRATION: Registered with the Core Outcome Measures in Effectiveness Trials (COMET) database, November 2019. https://www.comet-initiative.org/Studies/Details/1497. BioMed Central 2021-05-10 /pmc/articles/PMC8111763/ /pubmed/33971941 http://dx.doi.org/10.1186/s13063-021-05291-9 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Study Protocol
Bateman, Marcus
Evans, Jonathan P.
Vuvan, Viana
Jones, Val
Watts, Adam C.
Phadnis, Joideep
Bisset, Leanne
Vicenzino, Bill
Protocol for the development of a core outcome set for lateral elbow tendinopathy (COS-LET)
title Protocol for the development of a core outcome set for lateral elbow tendinopathy (COS-LET)
title_full Protocol for the development of a core outcome set for lateral elbow tendinopathy (COS-LET)
title_fullStr Protocol for the development of a core outcome set for lateral elbow tendinopathy (COS-LET)
title_full_unstemmed Protocol for the development of a core outcome set for lateral elbow tendinopathy (COS-LET)
title_short Protocol for the development of a core outcome set for lateral elbow tendinopathy (COS-LET)
title_sort protocol for the development of a core outcome set for lateral elbow tendinopathy (cos-let)
topic Study Protocol
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8111763/
https://www.ncbi.nlm.nih.gov/pubmed/33971941
http://dx.doi.org/10.1186/s13063-021-05291-9
work_keys_str_mv AT batemanmarcus protocolforthedevelopmentofacoreoutcomesetforlateralelbowtendinopathycoslet
AT evansjonathanp protocolforthedevelopmentofacoreoutcomesetforlateralelbowtendinopathycoslet
AT vuvanviana protocolforthedevelopmentofacoreoutcomesetforlateralelbowtendinopathycoslet
AT jonesval protocolforthedevelopmentofacoreoutcomesetforlateralelbowtendinopathycoslet
AT wattsadamc protocolforthedevelopmentofacoreoutcomesetforlateralelbowtendinopathycoslet
AT phadnisjoideep protocolforthedevelopmentofacoreoutcomesetforlateralelbowtendinopathycoslet
AT bissetleanne protocolforthedevelopmentofacoreoutcomesetforlateralelbowtendinopathycoslet
AT vicenzinobill protocolforthedevelopmentofacoreoutcomesetforlateralelbowtendinopathycoslet